Miromatrix Medical is a biotechnology business based in the US. Miromatrix Medical shares (MIRO) are listed on the NASDAQ and all prices are listed in US Dollars. Miromatrix Medical employs 61 staff and has a trailing 12-month revenue of around $31,115.
How to buy Miromatrix Medical stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – MIRO. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Miromatrix Medical stock price (NASDAQ: MIRO)
Use our graph to track the performance of MIRO stocks over time.Miromatrix Medical shares at a glance
Latest market close | $3.27 |
---|---|
52-week range | $2.02 - $4.95 |
50-day moving average | $3.56 |
200-day moving average | $3.61 |
Wall St. target price | $15.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.34 |
Buy Miromatrix Medical stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Miromatrix Medical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Miromatrix Medical price performance over time
Historical closes compared with the close of $3.27 from 2023-01-26
1 week (2023-01-20) | 9.00% |
---|---|
1 month (2022-12-28) | 16.79% |
3 months (2022-10-28) | -16.79% |
6 months (2022-07-28) | 22.01% |
1 year (2022-01-28) | -17.84% |
---|---|
2 years (2021-01-24) | N/A |
3 years (2020-01-24) | N/A |
5 years (2018-01-24) | N/A |
Miromatrix Medical financials
Revenue TTM | $31,115 |
---|---|
Gross profit TTM | $-466,934 |
Return on assets TTM | -34.15% |
Return on equity TTM | -61.93% |
Profit margin | 0% |
Book value | $1.57 |
Market capitalisation | $61.9 million |
TTM: trailing 12 months
Miromatrix Medical share dividends
We're not expecting Miromatrix Medical to pay a dividend over the next 12 months.
You may also wish to consider:
- Medtronic (MDT.US) (3.3% forward annual dividend yield)
Miromatrix Medical overview
Miromatrix Medical Inc. , a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Miromatrix Medical in the news
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer
Frequently asked questions
What percentage of Miromatrix Medical is owned by insiders or institutions?Currently 22.512% of Miromatrix Medical shares are held by insiders and 16.622% by institutions. How many people work for Miromatrix Medical?
Latest data suggests 61 work at Miromatrix Medical. When does the fiscal year end for Miromatrix Medical?
Miromatrix Medical's fiscal year ends in December. Where is Miromatrix Medical based?
Miromatrix Medical's address is: 6455 Flying Cloud Drive, Eden Prairie, MN, United States, 55344 What is Miromatrix Medical's ISIN number?
Miromatrix Medical's international securities identification number is: US60471P1084
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert